Companies › NVAX
NOVAVAX INC (NVAX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001000694 · EDGAR filings · Updated 2026-06-23
NOVAVAX INC (NVAX) has reported institutional ownership of 70.9%, with 258 institutional managers holding positions valued at $960.2M per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
- 2026-06-23 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, NOVAVAX INC has 258 institutional holders and institutional ownership of 70.9%.
Insider activity
Insiders reported 36 transactions (0 buys, 0 sells) across 12 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
PACIRA BIOSCIENCES INC COM (PCRX) · CADRE HLDGS INC (CDRE) · ARRIVENT BIOPHARMA INC (AVBP) · BIOLIFE SOLUTIONS INC COM NEW (BLFS) · FRESENIUS MEDICAL CARE AG (FMS) · PENNANT GROUP INC (PNTG)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.